DealStream Logo

Details

Jan 4, 2020A clinical stage company located in New Jersey developing a first-in class, patented/proprietary, orally-active product for Type 2 diabetes and metabolic syndrome. Highly motivated owner looking for buyers with a competitive offer. Product concept has been endorsed by leading endocrinologists. Clinical trial has been approved by the U.S. FDA and registered on [ external link ]: NCT03686657. Patent and Trademark issued by the U.S. Patent and Trademark office (USPTO). Anticipated market share is over $13B. Risk is mitigated by the results from the human proof-of-concept (PoC) studies. Product can also be developed for coexisting conditions such as NASH, PCOS and diabetic neuropathy. For more information visit: [ external link ]

Learn More About This Listing

Sign up for a free basic membership to start buying and selling. Learn about our membership plans.

By clicking "Join Now - It's Free" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.